{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T13:03:20Z","timestamp":1783515800314,"version":"3.55.0"},"reference-count":38,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2015,8,13]],"date-time":"2015-08-13T00:00:00Z","timestamp":1439424000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0134921","type":"journal-article","created":{"date-parts":[[2015,8,13]],"date-time":"2015-08-13T18:13:07Z","timestamp":1439489587000},"page":"e0134921","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":13,"title":["Efficacy of Ciprofloxacin for Treatment of Cholera Associated with Diminished Susceptibility to Ciprofloxacin to Vibrio cholerae O1"],"prefix":"10.1371","volume":"10","author":[{"given":"Wasif Ali","family":"Khan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debasish","family":"Saha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabeena","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed Abdus","family":"Salam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael Louis","family":"Bennish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,8,13]]},"reference":[{"key":"ref1","first-page":"515","author":"M.L. Bennish","year":"2003"},{"issue":"1","key":"ref2","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1056\/NEJMp1013771","article-title":"Antibiotics for both moderate and severe cholera","volume":"364","author":"E.J. Nelson","year":"2010","journal-title":"N Engl J Med"},{"key":"ref3","first-page":"229","author":"M.L. Bennish","year":"1994"},{"key":"ref4","author":"M.L. Bennish","year":"2008"},{"key":"ref5","first-page":"193","author":"M.L. Bennish","year":"2003"},{"issue":"9491","key":"ref6","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0140-6736(05)67290-X","article-title":"Single-dose ciprofloxacin versus 12-dose erythromycin for childhood cholera: a randomised controlled trial","volume":"366","author":"D. Saha","year":"2005","journal-title":"Lancet"},{"issue":".","key":"ref7","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/S0140-6736(96)01180-4","article-title":"Randomised controlled comparison of single-dose ciprofloxacin and doxycycline for cholera caused by Vibrio cholerae 01 or 0139","volume":"348","author":"W.A. Khan","year":"1996","journal-title":"Lancet"},{"issue":"6","key":"ref8","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1093\/clinids\/20.6.1485","article-title":"Ciprofloxacin for the treatment of cholera: a randomized, double-blind, controlled clinical trial of a single daily dose in Peruvian adults","volume":"20","author":"E. Gotuzzo","year":"1995","journal-title":"Clin Infect Dis"},{"issue":"23","key":"ref9","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1056\/NEJMoa054493","article-title":"Single-dose azithromycin for the treatment of cholera in adults","volume":"354","author":"D. Saha","year":"2006","journal-title":"N Engl J Med"},{"issue":"8","key":"ref10","doi-asserted-by":"crossref","first-page":"2676","DOI":"10.1128\/AAC.46.8.2676-2678.2002","article-title":"Role of active efflux in association with target gene mutations in fluoroquinolone resistance in clinical isolates of Vibrio cholerae","volume":"46","author":"S. Baranwal","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"ref11","doi-asserted-by":"crossref","first-page":"O292","DOI":"10.1111\/1469-0691.12393","article-title":"Haitian variant ctxB producing Vibrio cholerae O1 with reduced susceptibility to ciprofloxacin is persistent in Yavatmal, Maharashtra, India, after causing a cholera outbreak","volume":"20","author":"P. Kumar","year":"2014","journal-title":"Clin Microbiol Infect"},{"issue":"21","key":"ref12","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1001\/jama.2009.1750","article-title":"Susceptibility to fluoroquinolones of Vibrio cholerae O1 isolated from diarrheal patients in Zimbabwe","volume":"302","author":"M.S. Islam","year":"2009","journal-title":"JAMA"},{"issue":"1","key":"ref13","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0035-9203(95)90675-4","article-title":"Comparative trial of five antimicrobial compounds in the treatment of cholera in adults","volume":"89","author":"W.A. Khan","year":"1995","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"9023","key":"ref14","first-page":"296","article-title":"Randomised controlled comparison of single-dose ciprofloxacin and doxycycline for cholera caused by Vibrio cholerae 01 or 0139 [see comments]","volume":"348","author":"W.A. Khan","year":"1996","journal-title":"Lancet"},{"key":"ref15","unstructured":"Salam, M.A., et al., <italic>The Quest for New Drug in the Treatment of Cholera in Adults<\/italic>: <italic>Evaluation of Efficacy of Rifaximin in a Randomized<\/italic>, <italic>controlled Clinical Trial<\/italic>, in <italic>40th US-Japan Cholera Meeting<\/italic>. 2005: Boston."},{"issue":"4","key":"ref16","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1128\/IAI.62.4.1504-1506.1994","article-title":"Comparison of Vibrio cholerae O139 with V. cholerae O1 classical and El Tor biotypes","volume":"62","author":"K.E. Calia","year":"1994","journal-title":"Infection and immunity"},{"key":"ref17","unstructured":"NCCLS, <italic>Approved Standards M2-A6<\/italic>. <italic>Performance standards for antimicrobial disk susceptibility tests<\/italic>. National Committee for Clinical Laboratory Standards. Vol. 6th ed. NCCLS. 1997, Wayne, PA: National Centre for Clinical Laboratory Standards."},{"key":"ref18","unstructured":"CLSI, <italic>Approved document M100-S24<\/italic>. <italic>Performance Standards for Antimicrobial Susceptibility Testing; Twenty-Fourth Informational Supplement<\/italic>. 2014."},{"issue":"11","key":"ref19","doi-asserted-by":"crossref","first-page":"3572","DOI":"10.1128\/JCM.37.11.3572-3577.1999","article-title":"Detection of decreased fluoroquinolone susceptibility in Salmonellas and validation of nalidixic acid screening test","volume":"37","author":"A. Hakanen","year":"1999","journal-title":"J Clin Microbiol"},{"issue":"5","key":"ref20","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1111\/j.1469-0691.1997.tb00304.x","article-title":"Typhoid fever due to a Salmonella typhi strain of reduced susceptibility to fluoroquinolones","volume":"3","author":"O. Launay","year":"1997","journal-title":"Clin Microbiol Infect"},{"issue":"4","key":"ref21","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1046\/j.1469-0691.2000.00060-3.x","article-title":"Low-level resistance to fluoroquinolones among Salmonella and Shigella","volume":"6","author":"J.C. Nguyen","year":"2000","journal-title":"Clin Microbiol Infect"},{"issue":"11","key":"ref22","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1128\/AAC.37.11.2486","article-title":"Reduced susceptibilities of Shigella sonnei strains isolated from patients with dysentery to fluoroquinolones","volume":"37","author":"S. Horiuchi","year":"1993","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"ref23","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1136\/jcp.52.11.812","article-title":"Drug resistance in Campylobacter jejuni, C coli, and C lari isolated from humans in north west England and Wales, 1997","volume":"52","author":"R.T. Thwaites","year":"1999","journal-title":"J Clin Pathol"},{"issue":"7","key":"ref24","first-page":"389","article-title":"Outbreak of cholera caused by Vibrio cholerae 01 intermediately resistant to norfloxacin at Malda, West Bengal","volume":"98","author":"M.K. Bhattacharya","year":"2000","journal-title":"J Indian Med Assoc"},{"key":"ref25","first-page":"96","article-title":"Quinolone susceptibility of Vibrio cholerae O1 &amp; O139 isolates from Vellore","volume":"116","author":"M.V. Jesudason","year":"2002","journal-title":"Indian J Med Res"},{"key":"ref26","first-page":"153","article-title":"Resistance of Vibrio cholerae 01 to nalidixic acid","volume":"105","author":"M.V. Jesudason","year":"1997","journal-title":"Indian J Med Res"},{"issue":"Suppl 2","key":"ref27","doi-asserted-by":"crossref","first-page":"S120","DOI":"10.1086\/428052","article-title":"Mechanisms of resistance to quinolones","volume":"41","author":"G.A. Jacoby","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"11","key":"ref28","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1128\/AAC.39.11.2442","article-title":"Proposed criteria for interpretation of susceptibilities of strains of Neisseria gonorrhoeae to ciprofloxacin, ofloxacin, enoxacin, lomefloxacin, and norfloxacin","volume":"39","author":"J.S. Knapp","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"ref29","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1093\/tropej\/47.4.252","article-title":"Ciprofloxacin susceptible Salmonella typhi with treatment failure","volume":"47","author":"P. Dutta","year":"2001","journal-title":"J Trop Pediatr"},{"issue":"4","key":"ref30","doi-asserted-by":"crossref","first-page":"762","DOI":"10.3201\/eid0704.017436","article-title":"Enteric fever treatment failures: a global concern","volume":"7","author":"D.S. Chandel","year":"2001","journal-title":"Emerg Infect Dis"},{"issue":"1","key":"ref31","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1471-2334-5-37","article-title":"Clinical outcomes in typhoid fever: adverse impact of infection with nalidixic acid-resistant Salmonella typhi","volume":"5","author":"T. Kadhiravan","year":"2005","journal-title":"BMC Infect Dis"},{"issue":"6","key":"ref32","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1086\/516128","article-title":"Quinolone-resistant Salmonella typhi in Viet Nam: molecular basis of resistance and clinical response to treatment","volume":"25","author":"J. Wain","year":"1997","journal-title":"Clin Infect Dis"},{"issue":"1","key":"ref33","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1086\/375602","article-title":"Reevaluating fluoroquinolone breakpoints for Salmonella enterica serotype Typhi and for non-Typhi salmonellae","volume":"37","author":"J.A. Crump","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"2","key":"ref34","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jinf.2004.05.019","article-title":"Rifaximin a novel antimicrobial for enteric infections","volume":"50","author":"D.B. Huang","year":"2005","journal-title":"Journal of Infection"},{"issue":"4","key":"ref35","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1128\/AAC.47.4.1479-1480.2003","article-title":"Can Etest be used to determine Vibrio cholerae susceptibility to erythromycin?","volume":"47","author":"L.K. Ng","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"ref36","unstructured":"NCCLS, <italic>Performance Standards for Antimicrobial Susceptibility Testing<\/italic>: <italic>Twelfth Informational Supplement<\/italic>. NCCLS document M100-S12, 2002."},{"key":"ref37","unstructured":"Wells, J.G., <italic>Manual for the Laboratory Identification and Antimicrobial Susceptibility Testing of Bacterial Pathogens of Public Health Importance in the Developing World<\/italic>, in <italic>Haemophilus influenzae<\/italic>, <italic>Neisseria meningitides<\/italic>, <italic>Streptococcus pneumoniae<\/italic>, <italic>Neiseseria gonorrhoeae<\/italic>, <italic>Salmonella serotype Typhi<\/italic>, <italic>Shigella<\/italic>, <italic>and Vibrio cholerae<\/italic>, M.J. Perilla, et al., Editors. 2003, Switzerland: Geneva."},{"issue":"2","key":"ref38","first-page":"1","article-title":"Emergence of a unique, multi-drug resistant strain of Vibrio cholerae O1 in Bangladesh","volume":"3","year":"2005","journal-title":"Health and Science Bulletin (English)"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0134921","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,7]],"date-time":"2020-09-07T05:10:02Z","timestamp":1599455402000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0134921"}},"subtitle":[],"editor":[{"given":"Dongsheng","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,8,13]]},"references-count":38,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2015,8,13]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0134921","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,13]]}}}